Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05027139
Title A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Zymeworks Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego - Moores Cancer Center La Jolla California 92093 United States Details
UCLA Department of Medicine Hematology/Oncology Los Angeles California 90095 United States Details
UC Irvine Health - Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Astera Cancer Care East Brunswick New Jersey 08816 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Magee-Womens Hospital of UPMC Pittsburgh Pennsylvania 15213 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Vermont Medical Center Burlington Vermont 05401 United States Details
Northwest Medical Specialties, PLLC Tacoma Washington 98405 United States Details
University of Wisconsin - Madison Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field